Table 3.

Shows the changes primary and secondary outcomes in fatigue, sleep, anxiety and depression scores measured by MFI-20, PSQI, and HADS scales from T0 to T1.

	CBT (n = 44)			PLWNT (n = 45)			PLWNT vs. CBT
	T0	T1	Within	T0	T1	Within	Between
	($\stackrel{-}{X}$ ±S)	($\stackrel{-}{X}$ ±S)	group p	($\stackrel{-}{X}$ ±S)	($\stackrel{-}{X}$ ±S)	group P	group P
Primary outcome: MFI-20
General fatigue	10.932 ± 2.872	7.341± 3.403	0.000*	10.556 ± 2.896	6.511 ± 2.897	0.000*	0.516
Physical fatigue	10.614 ± 3.674	6.727± 3.172	0.000*	9.067± 3.962	4.511 ± 2.785	0.000*	0.435
Reduced activity	9.818 ± 3.611	6.545± 3.238	0.000*	8.622± 3.6, 200	4.0.911 ± 2.502	0.000*	0.593
Reduced motivation	8.091 ± 3.672	5.114± 2.508	0.000*	8.200± 4.257	4.644 ± 2.854	0.000*	0.482
Mental fatigue	9.886 ± 3.357	6.318± 2.752	0.000*	10.022 ± 4.104	5.578 ± 2.759	0.000*	0.282
Secondary outcome: PSQI
Total score	7.705 ± 2.953	5.295± 2.378	0.000*	6.756± 3.523	4.200 ± 2.085	0.000*	0.828
Subject sleep quality	1.545 ± 0.697	1.159± 0.079	0.002*	1.444± 0.724	0.956 ± 0.424	0.000*	0.532
Sleep latency	1.705 ± 0.904	1.386± 0.813	0.021*	1.333± 1.066	0.933 ± 0.720	0.011*	0.685
Sleep duration	1.023 ± 0.792	0.409± 0.622	0.000*	0.911± 0.821	0.200 ± 0.405	0.000*	0.609
Habitual sleep efficiency	0.455 ± 0.730	0.364± 0.718	0.439	0.644± 1.171	0.378 ± 0.912	0.209	0.142
Sleep disturbance	1.614 ± 0.618	1.205± 0.461	0.000*	1.467± 0.625	1.022 ± 0.452	0.000*	0.783
Sleep medicine using	0.091 ± 0.473	0.091± 0.291	1.000	0.200± 0.757	0.089 ± 0.468	0.168	0.326
Daytime dysfunction	1.273 ± 0.624	0.682± 0.601	0.000*	1.022± 0.657	0.356 ± 0.609	0.000*	0.593
Secondary outcome: HADS
Anxiety	7.682 ± 3.969	5.727± 3.083	0.000*	7.000± 3.855	4.111 ± 2.113	0.000*	0.198
Depression	6.705 ± 3.927	4.705± 3.069	0.001*	6.844± 4.033	3.444 ± 2.563	0.000*	0.105

^*P < 0.05.